Status:
TERMINATED
aHUS Observational Long Term Follow-Up
Lead Sponsor:
Alexion Pharmaceuticals, Inc.
Conditions:
Atypical Hemolytic Uremic Syndrome
Eligibility:
All Genders
Brief Summary
There is growing but limited information on the long term clinical status of aHUS patients who have previously received or are continuing to receive treatment with eculizumab. This study is designed t...
Eligibility Criteria
Inclusion
- aHUS patients who participated in any one of the aHUS-eculizumab clinical studies.
- aHUS patients or legal representative who are able and willing to given written informed consent for their study information to be collected and retained in a database.
Exclusion
- Not applicable.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT01522170
Start Date
March 1 2012
End Date
January 1 2017
Last Update
February 24 2017
Active Locations (56)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Healthcare - Children's Center
Atlanta, Georgia, United States
2
Dunwoody Pediatrics & Children's Healthcare of Atlanta
Dunwoody, Georgia, United States
3
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
4
Fort Wayne, Indiana, United States